- World rank, all time
- #36,500 of 42,892
- Rank in Japan
- #1,618 of 2,112
- Research works
- 197 ▲ 3% vs 2013–17
- Citations
- 2.8k 14.4 per fractional work
- Top-10% rate
- 3.0% record average 16.5%
- Open access
- 61% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 11.4×. Every wedge is a field page.
Who are the top researchers at Kyoto Pharmaceutical Industries (Japan)?
Ranked on the composite score, Mamoru Kanda, Hiroaki Shirahase and Seimei Osumi lead among researchers whose main affiliation is Kyoto Pharmaceutical Industries (Japan).
- 1 Mamoru Kanda Japan · #1,229,985 worldwide 22 citations · 23 works
- 2 Hiroaki Shirahase Japan · #1,363,344 worldwide 17 citations · 43 works
- 3 Seimei Osumi Japan · #1,562,849 worldwide 9 citations · 15 works
Which keywords describe research at Kyoto Pharmaceutical Industries (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Synthesis, Drug Discovery, Metabolism, Cancer, Oxidative Stress, Medicinal Chemistry and Anticancer Agents.
- Chemoprevention
- Green Chemistry
- Biological Activities
- Arachidonic Acid
- Heterocyclic Compounds
- Oligosaccharide Synthesis
- Macrocycles
- Cardiovascular Diseases
- Vascular Function
- Endothelial Dysfunction
- Cytochrome P450
- Biological Evaluation
- Transcriptional Regulation
- Antioxidant Activity
- Anticancer
- Cell Signaling
- Anticancer Agents
- Metabolism
- Cancer
- Synthesis
- Inflammation
- Oxidative Stress
- Drug Discovery
- Medicinal Chemistry
- Atherosclerosis
- Hypertension
- Reactive Oxygen Species
- Antimicrobial
- Antioxidant
- Nuclear Receptors
- Pharmacology
- Diabetes
- Protein-Protein Interactions
- Glycosidase Inhibitors
- Nitric Oxide
- Foldamers
- Peptide Synthesis
- Epoxyeicosatrienoic Acids
- Enantioselective Synthesis
- Asymmetric Synthesis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation34▲ 7.4×32 topics
- Synthesis19▲ 16×15 topics
- Oxidative Stress16▲ 4.3×20 topics
- Cancer15▲ 5.6×23 topics
- Drug Discovery14▲ 18×8 topics
- Metabolism13▲ 10×10 topics
- Medicinal Chemistry10▲ 13×7 topics
- Anticancer Agents9▲ 18×6 topics
- Atherosclerosis9▲ 12×7 topics
- Cell Signaling8▲ 13×8 topics
- Hypertension8▲ 12×8 topics
- Anticancer7▲ 19×6 topics
- Reactive Oxygen Species7▲ 7.5×6 topics
- Antioxidant Activity7▲ 6.5×7 topics
- Antimicrobial7▲ 13×4 topics
- Transcriptional Regulation7▲ 13×6 topics
- Antioxidant6▲ 4.7×13 topics
- Biological Evaluation6▲ 26×6 topics
- Nuclear Receptors6▲ 17×3 topics
- Cytochrome P4506▲ 42×2 topics
- Pharmacology6▲ 9.0×6 topics
- Endothelial Dysfunction6▲ 9.8×3 topics
- Diabetes6▲ 5.4×7 topics
- Vascular Function5▲ 20×3 topics
- Protein-Protein Interactions5▲ 25×2 topics
- Cardiovascular Diseases5▲ 22×1 topic
- Glycosidase Inhibitors5▲ 51×1 topic
- Macrocycles5▲ 26×2 topics
- Nitric Oxide5▲ 49×1 topic
- Oligosaccharide Synthesis5▲ 51×1 topic
- Foldamers5▲ 30×1 topic
- Heterocyclic Compounds5▲ 15×5 topics
- Peptide Synthesis5▲ 30×1 topic
- Arachidonic Acid5▲ 72×1 topic
- Epoxyeicosatrienoic Acids5▲ 72×1 topic
- Biological Activities4▲ 12×3 topics
- Enantioselective Synthesis4▲ 13×3 topics
- Green Chemistry4▲ 7.3×6 topics
- Asymmetric Synthesis4▲ 14×7 topics
- Chemoprevention4▲ 24×2 topics
Which research topics does Kyoto Pharmaceutical Industries (Japan) publish most on?
By volume in 2022–2025: Lysosomal Storage Disorders Research, Carbohydrate Chemistry and Synthesis, Bone health and treatments and Maritime Transport Emissions and Efficiency.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lysosomal Storage Disorders Research Physiology 1 works
- 2 Carbohydrate Chemistry and Synthesis Organic Chemistry 1 works
- 3 Bone health and treatments Oncology 1 works
- 4 Maritime Transport Emissions and Efficiency Environmental Engineering 0 works
- 5 Coastal and Marine Dynamics Earth-Surface Processes 0 works
- 6 Biochemical and Molecular Research Molecular Biology 0 works
- 7 Trypanosoma species research and implications Epidemiology 0 works
- 8 Bone Metabolism and Diseases Molecular Biology 0 works
- 9 Enzyme Production and Characterization Biotechnology 0 works
- 10 Synthesis and Characterization of Heterocyclic Compounds Organic Chemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kyoto Pharmaceutical Industries (Japan)'s research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kyoto
- Kyoto University
- Ritsumeikan University
- Kyoto Prefectural University of Medicine
- Kyoto Institute of Technology
- Doshisha University
- Kyoto Pharmaceutical University
- Ryukoku University
- Ōtani University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.